Organ-specific features of natural killer cells

Nature Reviews Immunology

Volumn 11, Issue 10, 2011, Pages 658-671

  Shi, Fu Dong ^a,b   Ljunggren, Hans Gustaf ^c   La Cava, Antonio ^d   Van Kaer, Luc ^e  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BRAIN DERIVED NEUROTROPHIC FACTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; COLONY STIMULATING FACTOR 1; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DACLIZUMAB; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLATIRAMER; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2A; OSTEOCLAST DIFFERENTIATION FACTOR; RANTES; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL INTERACTION; CELL MATURATION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CHRONIC LIVER DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; ENCEPHALITIS; HEPATITIS C; HUMAN; IMMUNE RESPONSE; INTESTINE; INTESTINE LYMPHATIC TISSUE; JOINT; KERATINOCYTE; KUPFFER CELL; LUNG; MICROGLIA; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NONHUMAN; PANCREAS; PANCREAS ISLET BETA CELL; PHENOTYPE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS VULGARIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; SKIN; STAPHYLOCOCCUS INFECTION; STELLATE CELL; TROPHOBLAST; UTERUS;

ANIMALS; AUTOIMMUNITY; BRAIN; CELL COMMUNICATION; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; JOINTS; KILLER CELLS, NATURAL; LIVER; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PANCREAS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; UTERUS;

EID: 80053131307     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3065     Document Type: Review

References (128)

1. Shi, F.-D. & Ransohoff, R. M. in Natural Killer Cells (eds Lotze, M. T. & Thomson, A. W.) 373-383 (Academic Press, Maryland Heights, 2010).
2. Shi, F. D. & Van Kaer, L. Reciprocal regulation between natural killer cells and autoreactive T cells. Nature Rev. Immunol. 6, 751-760 (2006). (Pubitemid 44453461)
3. French, A. R. & Yokoyama, W. M. Natural killer cells and autoimmunity. Arthritis Res. Ther. 6, 8-14 (2004). (Pubitemid 38256082)
4. Flodstrom-Tullberg, M., Bryceson, Y. T., Shi, F. D., Hoglund, P. & Ljunggren, H. G. Natural killer cells in human autoimmunity. Curr. Opin. Immunol. 21, 634-640 (2009).
5. Poirot, L., Benoist, C. & Mathis, D. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc. Natl Acad. Sci. USA 101, 8102-8107 (2004). (Pubitemid 38698061)
6. Feuerer, M., Shen, Y., Littman, D. R., Benoist, C. & Mathis, D. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity 31, 654-664 (2009).
7. Ogasawara, K. et al. NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20, 757-767 (2004). (Pubitemid 38757445)
8. Gur, C. et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nature Immunol. 11, 121-128 (2010).
9. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. & Tabira, T. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 186, 1677-1687 (1997). (Pubitemid 27506281)
10. Huang, D. et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20, 896-905 (2006). (Pubitemid 44943947)
11. Hao, J. et al. Central nervous system (CNS)-resident natural killer cells suppresses Th17 responses and CNS autoimmune pathology. J. Exp. Med. 207, 1907-1921 (2010).
12. Hao, J. et al. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann. Neurol. 69, 721-734 (2011).
13. Soderstrom, K. et al. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc. Natl Acad. Sci. USA 107, 13028-13033 (2010).
14. Wu, H. J. et al. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J. Exp. Med. 204, 1911-1922 (2007).
15. Hoglund, P. & Brodin, P. Current perspectives of natural killer cell education by MHC class I molecules. Nature Rev. Immunol. 10, 724-734 (2010).
16. Gregoire, C. et al. The trafficking of natural killer cells. Immunol. Rev. 220, 169-182 (2007). (Pubitemid 350045566)
17. Thapa, M., Kuziel, W. A. & Carr, D. J. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81, 3704-3713 (2007). (Pubitemid 46586867)
18. Jiang, D. et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J. Clin. Invest. 114, 291-299 (2004). (Pubitemid 39071634)
19. Wald, O. et al. IFN-γ acts on T cells to induce NK cell mobilization and accumulation in target organs. J. Immunol. 176, 4716-4729 (2006).
20. Widney, D. P. et al. CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung. Infect. Immun. 73, 485-493 (2005). (Pubitemid 40041143)
21. Liu, L. et al. Severe disease, unaltered leukocyte migration, and reduced IFN-γ production in CXCR3-/-mice with experimental autoimmune encephalomyelitis. J. Immunol. 176, 4399-4409 (2006). (Pubitemid 44264420)
22. Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185-194 (2007). (Pubitemid 46048465)
23. Morrison, B. E., Park, S. J., Mooney, J. M. & Mehrad, B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112, 1862-1870 (2003). (Pubitemid 38063709)
24. Stiles, L. N., Hardison, J. L., Schaumburg, C. S., Whitman, L. M. & Lane, T. E. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J. Immunol. 177, 8372-8380 (2006). (Pubitemid 44893799)
25. Yu, Y. R. et al. Defective antitumor responses in CX3CR1-deficient mice. Int. J. Cancer. 121, 316-322 (2007).
26. Hamann, I. et al. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 133, 62-73 (2011).
27. Hokeness, K. L., Kuziel, W. A., Biron, C. A. & Salazar-Mather, T. P. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-α/β-induced inflammatory responses and antiviral defense in liver. J. Immunol. 174, 1549-1556 (2005).
28. Salazar-Mather, T. P., Orange, J. S. & Biron, C. A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1α (MIP-1α)-dependent pathways. J. Exp. Med. 187, 1-14 (1998). (Pubitemid 28044815)
29. Flavell, R. A., Sanjabi, S., Wrzesinski, S. H. & Licona-Limon, P. The polarization of immune cells in the tumour environment by TGFβ. Nature Rev. Immunol. 10, 554-567 (2010).
30. Raulet, D. H. & Guerra, N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nature Rev. Immunol. 9, 568-580 (2009).
31. Cooper, M. A., Fehniger, T. A. & Caligiuri, M. A. The biology of human natural killer-cell subsets. Trends Immunol. 22, 633-640 (2001). (Pubitemid 33043908)
32. Fauriat, C., Long, E. O., Ljunggren, H. G. & Bryceson, Y. T. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115, 2167-2176 (2010).
33. Romagnani, C. et al. CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178, 4947-4955 (2007). (Pubitemid 46595277)
34. Chan, A. et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J. Immunol. 179, 89-94 (2007). (Pubitemid 46986521)
35. Bjorkstrom, N. K. et al. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116, 3853-3864 (2010).
36. Strowig, T., Brilot, F. & Munz, C. Noncytotoxic functions of NK cells: direct pathogen restriction and assistance to adaptive immunity. J. Immunol. 180, 7785-7791 (2008).
37. Ferlazzo, G. et al. The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33, 306-313 (2003). (Pubitemid 36267594)
38. Yu, Y. et al. Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. J. Immunol. 166, 1590-1600 (2001). (Pubitemid 32114639)
39. Hayakawa, Y. & Smyth, M. J. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176, 1517-1524 (2006). (Pubitemid 43134295)
40. Vivier, E. et al. Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49 (2011).
41. Lanier, L. L. Evolutionary struggles between NK cells and viruses. Nature Rev. Immunol. 8, 259-268 (2008). (Pubitemid 351432802)
42. Krueger, P. D., Lassen, M. G., Qiao, H. & Hahn, Y. S. Regulation of NK cell repertoire and function in the liver. Crit. Rev. Immunol. 31, 43-52 (2011).
43. McIntyre, K. W. & Welsh, R. M. Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection. J. Exp. Med. 164, 1667-1681 (1986). (Pubitemid 17184196)
44. Lassen, M. G., Lukens, J. R., Dolina, J. S., Brown, M. G. & Hahn, Y. S. Intrahepatic IL-10 maintains NKG2A+Ly49-liver NK cells in a functionally hyporesponsive state. J. Immunol. 184, 2693-2701 (2010).
45. Cooper, M. A. et al. Cytokine-induced memory-like natural killer cells. Proc. Natl Acad. Sci. USA 106, 1915-1919 (2009).
46. Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557-561 (2009).
47. Cooper, M. A. & Yokoyama, W. M. Memory-like responses of natural killer cells. Immunol. Rev. 235, 297-305 (2010).
48. Bjorkstrom, N. K. et al. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208, 13-21 (2011).
49. O'Leary, J. G., Goodarzi, M., Drayton, D. L. & von Andrian, U. H. T cell-and B cell-independent adaptive immunity mediated by natural killer cells. Nature Immunol. 7, 507-516 (2006).
50. Paust, S. et al. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nature Immunol. 11, 1127-1135 (2010).
51. Jinushi, M. et al. Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell-mediated induction of CD4 CD25 T cells with PD-1-dependent regulatory activities. Immunology 120, 73-82 (2007). (Pubitemid 44950472)
52. Jiang, W., Sun, R., Zhou, R., Wei, H. & Tian, Z. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J. Immunol. 182, 3768-3774 (2009).
53. Hajishengallis, G. & Lambris, J. D. Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol. 31, 154-163 (2010).
54. Roy, S. et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J. Immunol. 180, 1729-1736 (2008).
55. Knolle, P. et al. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. J. Hepatol. 22, 226-229 (1995).
56. Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669 (2008). (Pubitemid 351615417)
57. Mehal, W. & Imaeda, A. Cell death and fibrogenesis. Semin. Liver Dis. 30, 226-231 (2010).
58. Jinushi, M. et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 173, 6072-6081 (2004). (Pubitemid 39487763)
59. Nattermann, J. et al. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 55, 869-877 (2006). (Pubitemid 43764560)
60. Golden-Mason, L., Cox, A. L., Randall, J. A., Cheng, L. & Rosen, H. R. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Hepatology 52, 1581-1589 (2010).
61. Stegmann, K. A. et al. Interferon-α-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138, 1885-1897 (2010).
62. Ebert, L. M., Meuter, S. & Moser, B. Homing and function of human skin γδ T cells and NK cells: relevance for tumor surveillance. J. Immunol. 176, 4331-4336 (2006). (Pubitemid 44264412)
63. Ottaviani, C. et al. CD56brightCD16-NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur. J. Immunol. 36, 118-128 (2006). (Pubitemid 43116398)
64. Small, C. L. et al. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J. Immunol. 180, 5558-5568 (2008).
65. Reynders, A. et al. Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt-lymphoid cells. EMBO J. 30, 2934-2947 (2011).
66. Halim, T. Y. F. & Fumio, T. NK cell development from a novel progenitor found in the murine lung. J. Immunol. 182, 138.10 (2009).
67. Vonarbourg, C. et al. Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt+ innate lymphocytes. Immunity 33, 736-751 (2010).
68. Abreu, M. T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nature Rev. Immunol. 10, 131-144 (2010).
69. Guo, H. & Topham, D. J. Interleukin-22 (IL-22) production by pulmonary natural killer cells and the potential role of IL-22 during primary influenza virus infection. J. Virol. 84, 7750-7759 (2010).
70. Wilson, M. S. et al. Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J. Immunol. 184, 4378-4390 (2010).
71. Moffett, A. & Loke, C. Immunology of placentation in eutherian mammals. Nature Rev. Immunol. 6, 584-594 (2006). (Pubitemid 44134091)
72. Colucci, F., Boulenouar, S., Kieckbusch, J. & Moffett, A. How does variability of immune system genes affect placentation? Placenta 32, 39-45 (2011).
73. Croy, B. A., van den Heuvel, M. J., Borzychowski, A. M. & Tayade, C. Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones. Immunol. Rev. 214, 161-185 (2006). (Pubitemid 44707910)
74. Huntington, N. D., Vosshenrich, C. A. & Di Santo, J. P. Developmental pathways that generate natural-killer-cell diversity in mice and humans. Nature Rev. Immunol. 9, 703-714 (2007). (Pubitemid 47327395)
75. Moffett-King, A. Natural killer cells and pregnancy. Nature Rev. Immunol. 9, 656-663 (2002). (Pubitemid 37328723)
76. Yadi, H. et al. Unique receptor repertoire in mouse uterine NK cells. J. Immunol. 181, 6140-6147 (2008).
77. Male, V. et al. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J. Immunol. 185, 3913-3918 (2010).
78. Ashkar, A. A., Di Santo, J. P. & Croy, B. A. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med. 192, 259-270 (2000).
79. Hanna, J. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nature Med. 12, 1065-1074 (2006). (Pubitemid 44353388)
80. Sharkey, A. M. et al. Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age. J. Immunol. 181, 39-46 (2008).
81. Keskin, D. B. et al. TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16-NK cells with similarities to decidual NK cells. Proc. Natl Acad. Sci. USA 104, 3378-3383 (2007). (Pubitemid 46364167)
82. Hanna, J. et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16-human natural killer cells. Blood 102, 1569-1577 (2003). (Pubitemid 37022543)
83. Hiby, S. E. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965 (2004). (Pubitemid 39431121)
84. Hiby, S. E. et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J. Clin. Invest. 120, 4102-4110 (2010).
85. Brauner, H. et al. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J. Immunol. 184, 2272-2280 (2010).
86. Alba, A. et al. Natural killer cells are required for accelerated type 1 diabetes driven by interferon-β. Clin. Exp. Immunol. 151, 467-475 (2008). (Pubitemid 351160730)
87. Liu, R. et al. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J. Immunol. 176, 5247-5254 (2006).
88. Ansari, M. J. et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198, 63-69 (2003). (Pubitemid 36870186)
89. Flodstrom, M. et al. Target cell defense prevents the development of diabetes after viral infection. Nature Immunol. 3, 373-382 (2002). (Pubitemid 34308626)
90. Lee, I. F., Qin, H., Trudeau, J., Dutz, J. & Tan, R. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172, 937-942 (2004). (Pubitemid 38113752)
91. Beilke, J. N., Kuhl, N. R., Van Kaer, L. & Gill, R. G. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nature Med. 11, 1059-1065 (2005). (Pubitemid 41486827)
92. Tak, P. P. et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum. 37, 1735-1743 (1994). (Pubitemid 24371874)
93. Mack, M. et al. Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. Arthritis Rheum. 42, 981-988 (1999).
94. Iwamoto, T., Okamoto, H., Toyama, Y. & Momohara, S. Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients. FEBS J. 275, 4448-4455 (2008).
95. Dalbeth, N. et al. CD56bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J. Immunol. 173, 6418-6426 (2004). (Pubitemid 39487802)
96. Zhang, A. L. et al. Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 110, 2484-2493 (2007). (Pubitemid 47523170)
97. Romas, E., Gillespie, M. T. & Martin, T. J. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30, 340-346 (2002). (Pubitemid 34154863)
98. Lubberts, E. et al. Increase in expression of receptor activator of nuclear factor κB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. Arthritis Rheum. 46, 3055-3064 (2002). (Pubitemid 35315901)
99. Geusens, P. P. et al. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum. 54, 1772-1777 (2006). (Pubitemid 43877926)
100. Redzic, Z. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8, 3 (2011).
101. Trifilo, M. J. et al. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78, 585-594 (2004). (Pubitemid 38067580)
102. Alsharifi, M. et al. NK cell-mediated immunopathology during an acute viral infection of the CNS. Eur. J. Immunol. 36, 887-896 (2006).
103. Hayashi, T. et al. Critical roles of NK and CD8+ T cells in central nervous system listeriosis. J. Immunol. 182, 6360-6368 (2009).
104. Alizadeh, D. et al. Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy. Clin. Cancer Res. 16, 3399-3408 (2010).
105. Lunemann, A. et al. Human NK cells kill resting but not activated microglia via NKG2D-and NKp46-mediated recognition. J. Immunol. 181, 6170-6177 (2008).
106. Ponomarev, E. D. et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J. Immunol. 178, 39-48 (2007). (Pubitemid 46039660)
107. Biber, K., Neumann, H., Inoue, K. & Boddeke, H. W. Neuronal 'on' and 'off' signals control microglia. Trends Neurosci. 30, 596-602 (2007). (Pubitemid 350051426)
108. Hanisch, U. K. & Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neurosci. 10, 1387-1394 (2007). (Pubitemid 350014685)
109. Farina, C., Aloisi, F. & Meinl, E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28, 138-145 (2007). (Pubitemid 46283692)
110. Ponomarev, E. D., Shriver, L. P., Maresz, K. & Dittel, B. N. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J. Neurosci. Res. 81, 374-389 (2005). (Pubitemid 41359292)
111. Bhat, R. & Steinman, L. Innate and adaptive autoimmunity directed to the central nervous system. Neuron 64, 123-132 (2009).
112. Rose, J. W., Watt, H. E., White, A. T. & Carlson, N. G. Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann. Neurol. 56, 864-867 (2004). (Pubitemid 39578450)
113. Rose, J. W. et al. Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Neurology 69, 785-789 (2007). (Pubitemid 47300936)
114. Bielekova, B. et al. Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl Acad. Sci. USA 103, 5941-5946 (2006).
115. Bielekova, B. et al. Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch. Neurol. 66, 483-489 (2009).
116. Vandenbark, A. A. et al. Interferon-β-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis. J. Neuroimmunol. 215, 125-128 (2009).
117. Sand, K. L., Knudsen, E., Rolin, J., Al-Falahi, Y. & Maghazachi, A. A. Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate. Cell. Mol. Life Sci. 66, 1446-1456 (2009).
118. Paya, C. V., Patick, A. K., Leibson, P. J. & Rodriguez, M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143, 95-102 (1989). (Pubitemid 19174205)
119. Bartholomaus, I. et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462, 94-98 (2009).
120. Fan, Z. et al. In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response. Nature Med. 16, 718-722 (2010).
121. Siffrin, V. et al. In vivo imaging of partially reversible Th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity 33, 424-436 (2010).
122. Bajenoff, M. et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J. Exp. Med. 203, 619-631 (2006).
123. Chen, Q., Khoury, M. & Chen, J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage in humanized mice. Proc. Natl Acad. Sci. USA 106, 21783-21788 (2009).
124. Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nature Immunol. 12, 21-27 (2011).
125. Walzer, T. et al. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nature Immunol. 8, 1337-1344 (2007). (Pubitemid 350131171)
126. Tu, Z. et al. TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205, 233-244 (2008). (Pubitemid 351185729)
127. Bluestone, J. A., Herold, K. & Eisenbarth, G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature 464, 1293-1300 (2010).
128. Sternberg, E. M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Rev. Immunol. 6, 318-328 (2006).